Stephen P. Squinto

EVP & Head of Research, Alexion Pharmaceuticals.

Companies

SpringWorks Therapeutics, Inc.Board member Sep 12, 2019 to May 20, 2022¹
Compass Therapeutics, Inc.Board member Jun 23, 2020 to Feb 23, 2022²
Chemomab Therapeutics Ltd.Board member Mar 25, 2021 to Apr 21, 2021³
Passage BIO, Inc.Board member Feb 27, 2020 to Mar 2, 2020⁴
Passage BIO, Inc.Head of Research and Dev Feb 27, 2020 to Mar 2, 2020⁴
Alexion PharmaceuticalsEVP & Head of Research Jan 10, 2006 to Oct 28, 2014⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

SpringWorks Therapeutics, Inc.6,317,959 shares⁶May 20, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

May 19, 2022Granted 4,818 shares of SpringWorks Therapeutics, Inc.⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARSpringWorks Therapeutics, Inc., Board member
2
SEC EDGARCompass Therapeutics, Inc., Board member
3
SEC EDGARChemomab Therapeutics Ltd., Board member
4
SEC EDGARPassage BIO, Inc., Board member
5
SEC EDGARAlexion Pharmaceuticals, EVP & Head of Research
6
SEC EDGARSpringWorks Therapeutics, Inc. shares after the filing of May 20, 2022